Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Cipla reported INR56.48B in Current Liabilities for its fiscal quarter ending in September of 2023.

Current Liabilities Change Date
Aceragen USD 17.86M 3.56M Mar/2023
Adamis Pharmaceuticals USD 12.95M 1.55M Mar/2023
Agile Therapeutics USD 17.54M 2.23M Sep/2023
Bio Path USD 1.36M 69K Sep/2023
Brainstorm Cell Therapeutics USD 6.32M 1.37M Sep/2023
Capricor Therapeutics USD 32.93M 2.23M Sep/2023
Cara Therapeutics USD 22.88M 2.58M Sep/2023
Esperion Therapeutics USD 137.71M 30.54M Sep/2023
Immunic USD 17.78M 460K Sep/2023
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Life Technologies USD 12.88M 513K Sep/2023
Lumos Pharma USD 6.12M 429K Sep/2023
Minerva Neurosciences USD 3.35M 1.44M Sep/2023
Nektar Therapeutics USD 52.11M 1.42M Sep/2023
TherapeuticsMD USD 14.51M 148K Sep/2023